Type I interferon pathway activation in connective tissue disease associated interstitial lung disease - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Activation of the Type I Interferon Pathway in Interstitial Lung Disease Linked to Connective Tissue Disorders

  • By

  • Tobias M. Defesche

  • Thomas Koudstaal

  • Marjan A. Versnel

  • Odilia B.J. Corneth

  • Zana Brkic

  • June 11, 2026

Share

Objective:

Revise to include direct attribution.

Key Findings:
  • Add citations or references to specific studies.
Interpretation:

Remove unsupported conclusions.

Limitations:
  • Expand with context from the source.
Conclusion:

Revise to reflect only what is stated in the source.

Original Source(s)

Type I interferon pathway activation in connective tissue disease associated interstitial lung disease

  • by Tobias M. Defesche, Thomas Koudstaal, Marjan A. Versnel, Odilia B.J. Corneth, Zana Brkic

  • June 11, 2026

Related Content

Promoting mental health in intensive care unit onboarding: a consensus-based iterative development of a competency-based framework

MSCs and MSC-Exos in pediatric ARDS treatment: translational research and the reshaping of nursing roles

Robotic-assisted bronchoscopy combined with digital tomosynthesis for pulmonary nodules characterization: a single center experience